Synthesis, antibacterial and anticonvulsant evaluations of some cyclic enaminones

European Journal of Medicinal Chemistry

Volumn 44, Issue 3, 2009, Pages 967-975

  Edafiogho, Ivan O ^a   Phillips, Oludotun A ^a   Udo, Edet E ^a   Samuel, Santosh ^a   Rethish, Beigy ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Anticonvulsant; Enaminone esters; Oxazolidinones; UV data

Indexed keywords

ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; CARBOXYLIC ACID DERIVATIVE; ETHYL 4 (3 FLUORO 4 MORPHOLINOPHENYLAMINO) 2 OXO 6 PHENYLCYCLOHEX 3 ENE 1 CARBOXYLATE; ETHYL 4 (3 FLUORO 4 MORPHOLINOPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENE 1 CARBOXYLATE; ETHYL 4 [4 (2 FLUORO 4 NITROPHENYL)PIPERAZIN 1 YL] 2 OXO 6 PHENYLCYCLOHEX 3 ENE 1 CARBOXYLATE; ETHYL 4 [4 (2 FLUORO 4 NITROPHENYL)PIPERAZIN 1 YL] 6 METHYL 2 OXOCYCLOHEX 3 ENE 1 CARBOXYLATE; ETHYL 4 [[3 (3 FLUORO 4 MORPHOLINOPHENYL) 2 OXOOXAZOLIDIN 5 YL]METHYLAMINO] 6 METHYL 2 OXOCYCLOHEX 3 ENE 1 CARBOXYLATE; LINEZOLID; METHYL 4 (3 FLUORO 4 MORPHOLINOPHENYLAMINO) 2 OXO 6 PHENYLCYCLOHEX 3 ENE 1 CARBOXYLATE; METHYL 4 (3 FLUORO 4 MORPHOLINOPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENE 1 CARBOXYLATE; METHYL 4 [4 (2 FLUORO 4 NITROPHENYL)PIPERAZIN 1 YL] 2 OXO 6 PHENYLCYCLOHEX 3 ENE 1 CARBOXYLATE; METHYL 4 [[3 (3 FLUORO 4 MORPHOLINOPHENYL) 2 OXOOXAZOLIDIN 5 YL]METHYLAMINO] 2 OXO 6 PHENYLCYCLOHEX 3 ENE 1 CARBOXYLATE; METHYL 4 [[3 (3 FLUORO 4 MORPHOLINOPHENYL) 2 OXOOXAZOLIDIN 5 YL]METHYLAMINO] 6 METHYL 2 OXOCYCLOHEX 3 ENECARBOXYLATE; OXAZOLIDINONE DERIVATIVE; TERT BUTYL 4 [2 FLUORO 4 [3 HYDROXY 4 (METHOXYCARBONYL) 5 PHENYLCYCLOHEX 1 ENYLAMINO]PHENYL]PIPERAZINE 1 CARBOXYLATE; TERT BUTYL 4 [2 FLUORO 4 [4 (METHOXYCARBONYL) 5 METHYL 3 OXOCYCLOHEX 1 ENYLAMINO]PHENYL]PIPERAZINE 1 CARBOXYLATE; TERT BUTYL 4 [4 [4 (ETHOXYCARBONYL) 3 OXO 5 PHENYLCYCLOHEX 1 ENYLAMINO] 2 FLUOROPHENYL]PIPERAZINE 1 CARBOXYLATE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

AMINES; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; MAGNETIC RESONANCE SPECTROSCOPY; SPECTROPHOTOMETRY, ULTRAVIOLET; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 60549105375     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2008.07.005     Document Type: Article

References (25)

1. Stables J.P., and Kupferberg H.J. The NIH anticonvulsant drug development (ADD) program: preclinical anticonvulsant screening project. In: Avazini G., Tanganelli P., and Avoli M. (Eds). Molecular and Cellular Targets for Anti-epileptic Drugs (1997), John Libbey and Co., London 191-198
2. Edafiogho I.O., Kombian S.B., Ananthalakshmi K.V.V., Salama N.N., Eddington N.D., Wilson T.L., Alexander M.S., Jackson P.L., Hanson C.D., and Scott K.R. J. Pharm. Sci. 96 (2007) 2509-2531
3. Swaney S.M., Aoki H., Ganoza M.C., and Shinabarger D.L. Antimicrob. Agents Chemother. 42 (1998) 3251-3255
4. Aoki H., Ke L., Poppe S.M., Poel T.J., Weaver E.A., Gadwood R.C., Thomas R.C., Shinabarger D.L., and Ganoza M.C. Antimicrob. Agents Chemother. 46 (2002) 1080-1085
5. Clemett D., and Markham A. Drugs 59 4 (2000) 815-827
6. Phillips O.A. Curr. Opin. Invest. Drugs 4 (2003) 117-127
7. Barbachyn M.R., and Ford C.W. Angew. Chem., Int. Ed. 42 (2003) 2010
8. Gravestock M.B. Curr. Opin. Drug Discov. Dev. 8 4 (2005) 469-477
9. Hutchinson D.K. Curr. Top. Med. Chem. 3 9 (2003) 1021-1042
10. Phillips O.A. Bioorg. Med. Chem. 11 (2003) 35-41
11. Brickner S.J., Hutchinson D.K., Barbachyn M.R., Manninen P.R., Ulanowicz D.A., Garmon S.A., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., and Zurenko G.E. J. Med. Chem. 39 (1996) 673-679
12. Edafiogho I.O., Phillips O.A., Abdel-Hamid M., Ali A.A.M., Matowe W.C., El-Hashim A., and Kombian S.B. Bioorg. Med. Chem. 10 (2002) 593-597
13. Scott K.R., Rankin G.O., Stables J.P., Alexander M.S., Edafiogho I.O., Farrar V.A., Kolen K.R., Moore J.A., Simms L.D., and Tonnu A.D. J. Med. Chem. 38 (1995) 4033-4043
14. Scott K.R., Edafiogho I.O., Richardson E.L., Farrar V.A., Moore J.A., Tietz E.I., Hinko C.N., Chang H., Assadi A., and Nicholson J.M. J. Med. Chem. 36 (1993) 1947-1955
15. Edafiogho I.O., Moore J.A., Farrar V.A., Nicholson J.M., and Scott K.R. J. Pharm. Sci. 83 (1994) 79-84
16. Edafiogho I.O., Ananthalakshmi K.V.V., and Kombian S.B. Bioorg. Med. Chem. 14 (2006) 5266-5277
17. Kombian S.B., Edafiogho I.O., and Ananthalakshmi K.V.V. Br. J. Pharmacol. 145 (2005) 945-953
18. Ananthalakshmi K.V.V., Edafiogho I.O., and Kombian S.B. Neuroscience 141 (2006) 345-356
19. Kombian S.B., Edafiogho I.O., and Ananthalakshmi K.V.V. Eur. J. Neurosci. 141 (2006) 345-356
20. Ananthalakshmi K.V.V., Edafiogho I.O., and Kombian S.B. Epilepsy Res. 76 (2007) 85-92
21. Greenhill J.V. J. Chem. Soc., Perkin Trans. 1 (1976) 2209-2211
22. Edafiogho I.O., Hinko C.N., Chang H., Moore J.A., Mulzac D., Nicholson J.M., and Scott K.R. J. Med. Chem. 35 (1992) 2798-2805
23. Edafiogho I.O., Alexander M.S., Moore J.A., Farrar V.A., and Scott K.R. Curr. Med. Chem. 1 (1994) 159-178
24. CS Chem Draw Ultra Version 6.01, Computer Software by CambridgeSoft.Com.
25. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. fourth ed. Approved Standard. NCCLS Document M7-A4 (1997), National Committee for Clinical Laboratory Standards, Villanova, PA